396 - Streamlining Mucositis at the University of Rochester Medical Center: A retrospective chart review and pilot study

Streamlining Mucositis Management Protocol at University of Rochester Medical Center, Razban G, Bolude J, Sahler OJ, Shah R, Shope E (Eastman Institute for Oral Health, Golisano Children’s Hospital, Rochester, NY)

Purpose: Determine if the University of Rochester Pediatric Hematology/Oncology Division’s clinical practice aligns with current recommendations and evidence-based research in the prevention and/or treatment of mucositis. This project served as a pilot study to aid development of protocols to improve mucositis prevention and treatment outcomes at URMC.

Methods: A retrospective chart review of all pediatric oncology patients who presented with mucositis over the span of 24 months was completed. Grade of mucositis, completion of dental consult, completion of mucositis education, and type of supportive care administered were collected. We sought to compare how URMC’s current standard of care compares to the recommended guidelines by MASCC (Multinational Association of Supportive Care in Cancer) /ISOO (International Society of Oral Oncology).

Results: Seventy-nine percent of patients that were seen at URMC’s pediatric oncology division did not receive a dental consult and seventy-five percent of patients did not have mucositis teachings from the medical or dental team. Grades of mucositis seen inpatient and outpatient varied from one to four based on the World Health Organization (WHO) mucositis scale.

Conclusions: Based on our findings, URMC failed to meet current standards for prevention and care of mucositis. Thus, a protocol including the dental team for clearances prior to cancer treatment, education, and involvement throughout cancer treatment is needed. Teachings with the nursing team will need to be established for daily care.